vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and SPIRE INC (SR). Click either name above to swap in a different company.

SPIRE INC is the larger business by last-quarter revenue ($762.2M vs $749.2M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). SPIRE INC runs the higher net margin — 12.5% vs 3.6%, a 8.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 13.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -17.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Spire Inc. is a regional public utility holding company based in St. Louis, Missouri, providing natural gas service through its regulated core utility operations while engaging in non-regulated activities that provide business opportunities. Its primary subsidiary Laclede Gas Company is the largest natural gas distribution utility in Missouri, serving approximately 631,000 residential, commercial and industrial customers in the City of St. Louis and ten counties in eastern Missouri. Its corpo...

CLOV vs SR — Head-to-Head

Bigger by revenue
SR
SR
1.0× larger
SR
$762.2M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+48.1% gap
CLOV
62.0%
13.9%
SR
Higher net margin
SR
SR
8.8% more per $
SR
12.5%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-17.8%
SR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
SR
SR
Revenue
$749.2M
$762.2M
Net Profit
$27.3M
$95.0M
Gross Margin
55.1%
Operating Margin
3.6%
22.8%
Net Margin
3.6%
12.5%
Revenue YoY
62.0%
13.9%
Net Profit YoY
16.9%
EPS (diluted)
$0.05
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SR
SR
Q1 26
$749.2M
Q4 25
$487.7M
$762.2M
Q3 25
$496.6M
$334.1M
Q2 25
$477.6M
$421.9M
Q1 25
$462.3M
$1.1B
Q4 24
$337.0M
$669.1M
Q3 24
$331.0M
$293.8M
Q2 24
$356.3M
$414.1M
Net Profit
CLOV
CLOV
SR
SR
Q1 26
$27.3M
Q4 25
$-49.3M
$95.0M
Q3 25
$-24.4M
$-39.8M
Q2 25
$-10.6M
$20.9M
Q1 25
$-1.3M
$209.3M
Q4 24
$-22.1M
$81.3M
Q3 24
$-9.2M
$-25.9M
Q2 24
$7.4M
$-12.6M
Gross Margin
CLOV
CLOV
SR
SR
Q1 26
Q4 25
55.1%
Q3 25
Q2 25
Q1 25
Q4 24
55.6%
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
SR
SR
Q1 26
3.6%
Q4 25
-10.1%
22.8%
Q3 25
-4.9%
-0.1%
Q2 25
-2.2%
16.4%
Q1 25
-0.3%
29.1%
Q4 24
-6.4%
22.2%
Q3 24
-2.7%
6.7%
Q2 24
2.0%
7.4%
Net Margin
CLOV
CLOV
SR
SR
Q1 26
3.6%
Q4 25
-10.1%
12.5%
Q3 25
-4.9%
-11.9%
Q2 25
-2.2%
5.0%
Q1 25
-0.3%
19.9%
Q4 24
-6.6%
12.2%
Q3 24
-2.8%
-8.8%
Q2 24
2.1%
-3.0%
EPS (diluted)
CLOV
CLOV
SR
SR
Q1 26
$0.05
Q4 25
$1.54
Q3 25
$-0.77
Q2 25
$0.29
Q1 25
$3.51
Q4 24
$1.34
Q3 24
$-0.63
Q2 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SR
SR
Cash + ST InvestmentsLiquidity on hand
$177.6M
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$3.4B
Total Assets
$697.7M
$11.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SR
SR
Q1 26
$177.6M
Q4 25
$78.3M
$4.1M
Q3 25
$5.7M
Q2 25
$13.1M
Q1 25
$15.2M
Q4 24
$194.5M
$11.5M
Q3 24
$288.0M
$4.5M
Q2 24
$254.8M
$7.4M
Stockholders' Equity
CLOV
CLOV
SR
SR
Q1 26
$339.4M
Q4 25
$308.7M
$3.4B
Q3 25
$340.9M
$3.4B
Q2 25
$344.2M
$3.5B
Q1 25
$336.1M
$3.5B
Q4 24
$341.1M
$3.3B
Q3 24
$342.2M
$3.2B
Q2 24
$324.9M
$3.3B
Total Assets
CLOV
CLOV
SR
SR
Q1 26
$697.7M
Q4 25
$541.0M
$11.9B
Q3 25
$559.7M
$11.6B
Q2 25
$575.0M
$11.4B
Q1 25
$583.7M
$11.3B
Q4 24
$580.7M
$11.3B
Q3 24
$653.0M
$10.9B
Q2 24
$674.2M
$10.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SR
SR
Operating Cash FlowLast quarter
$81.0M
Free Cash FlowOCF − Capex
$-121.8M
FCF MarginFCF / Revenue
-16.0%
Capex IntensityCapex / Revenue
26.6%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$-286.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SR
SR
Q1 26
Q4 25
$-66.9M
$81.0M
Q3 25
$12.1M
$-4.9M
Q2 25
$5.4M
$129.1M
Q1 25
$-16.3M
$372.7M
Q4 24
$34.8M
$81.1M
Q3 24
$50.0M
$82.9M
Q2 24
$44.8M
$270.1M
Free Cash Flow
CLOV
CLOV
SR
SR
Q1 26
Q4 25
$-69.0M
$-121.8M
Q3 25
$11.4M
$-227.6M
Q2 25
$4.8M
$-91.4M
Q1 25
$-16.5M
$154.1M
Q4 24
$33.3M
$-179.5M
Q3 24
$49.6M
$-146.9M
Q2 24
$44.4M
$47.9M
FCF Margin
CLOV
CLOV
SR
SR
Q1 26
Q4 25
-14.1%
-16.0%
Q3 25
2.3%
-68.1%
Q2 25
1.0%
-21.7%
Q1 25
-3.6%
14.7%
Q4 24
9.9%
-26.8%
Q3 24
15.0%
-50.0%
Q2 24
12.5%
11.6%
Capex Intensity
CLOV
CLOV
SR
SR
Q1 26
Q4 25
0.4%
26.6%
Q3 25
0.1%
66.7%
Q2 25
0.1%
52.3%
Q1 25
0.0%
20.8%
Q4 24
0.5%
38.9%
Q3 24
0.1%
78.2%
Q2 24
0.1%
53.7%
Cash Conversion
CLOV
CLOV
SR
SR
Q1 26
Q4 25
0.85×
Q3 25
Q2 25
6.18×
Q1 25
1.78×
Q4 24
1.00×
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SR
SR

Residential$474.9M62%
Commercial And Industrial$148.4M19%
Gas Marketing$41.1M5%
Midstream$39.0M5%
Transportation$37.1M5%
Offsystem And Other Inventive$19.7M3%
Other Customer Revenue$4.6M1%

Related Comparisons